$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
What's in Store for Pacific Biosciences' (PACB) Q4 Earnings?
10:37am, Tuesday, 09'th Feb 2021
Pacific Biosciences' (PACB) fourth-quarter results are likely to reflect strength in its Sequel system.
Pacific Biosciences Earnings Preview
10:23am, Tuesday, 09'th Feb 2021
On Wednesday, February 10, Pacific Biosciences (NASDAQ:PACB) will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Pacific Biosciences Grants Equity Incentive Award to New Employee
05:00pm, Friday, 05'th Feb 2021
MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequen
Is Pacific Biosciences of California a Ticking Time Bomb for Investors?
06:12am, Tuesday, 02'nd Feb 2021
A new leadership team is betting that it can make long-read genome sequencing more competitive.
Pacific Biosciences Grants Equity Incentive Award to New Employee
04:15pm, Friday, 29'th Jan 2021
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequen
Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call
02:30pm, Wednesday, 27'th Jan 2021
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial result
Should You Book Profits In Pacific Biosciences of California After A Massive 13x Rally?
07:30am, Monday, 25'th Jan 2021
After a large 13x rise since the March 23 levels of last year, at the current price of around $36 per share we believe Pacific Biosciences of California stock, a biotechnology company that develops ge
Why You Should Retain Pacific Biosciences (PACB) Stock Now
12:48pm, Wednesday, 20'th Jan 2021
Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects.
ARKG: Potential Disruption For Healthcare And Pharma Industries
01:56pm, Tuesday, 19'th Jan 2021
ARKG: Potential Disruption For Healthcare And Pharma Industries
Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues
12:02pm, Wednesday, 13'th Jan 2021
Pacific Biosciences' (PACB) preliminary Q420 revenues are expected to improve from Q320.
Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform
08:02am, Wednesday, 13'th Jan 2021
New platform expected to make whole genome sequencing significantly more affordable and accessible for use in mainstream medical care New platform expected to make whole genome sequencing significantl
Pacific Biosciences Grants Equity Incentive Awards to New Employees
06:26pm, Tuesday, 12'th Jan 2021
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long
Pacific Biosciences of California, Inc. Announces Preliminary Fourth Quarter 2020 Revenue
07:45am, Monday, 11'th Jan 2021
MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing platforms, today announc
MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments
Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative
08:00am, Friday, 08'th Jan 2021
Seven new Sequel IIe Systems will support expanded generation of high-quality genomes for improving fundamental understanding of biology and aiding biodiversity conservation Seven new Sequel IIe Syste
Sign In
Buy PACB